Share Search
Visit the Share Search
Arecor Therape Accounts Summary
| Date of Accounts | 2022 | 2021 | 2020 | ||
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | ||
| Millions | Millions | Millions | |||
| Income Statement | 31-12-2022 | 31-12-2021 | 31-12-2020 | ||
| Revenue | 2.40 | 1.16 | 1.70 | ||
| Operating Profit / Loss | -10.63 | -6.44 | -3.43 | ||
| Net Interest | 0.09 | -0.51 | n/a | ||
| Pre Tax Profit | -10.54 | -6.95 | -3.51 | ||
| Post Tax Profit | -9.26 | -6.17 | -2.75 | ||
| Profit for the Period | -9.26 | -6.17 | -2.75 | ||
| Equity Holders of Parent Company | -9.26 | -6.17 | -2.75 | ||
| Minority Interests | n/a | n/a | n/a | ||
| Continuing EPS | |||||
| Earnings per Share (Basic) | -32.00p | -27.00p | -17.00p | ||
| Earnings per Share (Diluted) | -32.00p | -27.00p | -17.00p | ||
| Earnings per Share (Adjusted) | -32.00p | -27.00p | -17.00p | ||
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -32.00p | -27.00p | -17.00p | ||
| Earnings per Share (Diluted) | -32.00p | -27.00p | -17.00p | ||
| Earnings per Share (Adjusted) | -32.00p | -27.00p | -17.00p | ||
| Dividend per Share | n/ap | n/ap | n/ap | ||
| Millions | Millions | Millions | |||
| Balance Sheet | 31-12-2022 | 31-12-2021 | 31-12-2020 | ||
| Non-Current Assets | |||||
| Intangible Assets | 3.40 | 0.03 | 0.04 | ||
| Property, Plant and Equipment | 0.84 | 0.33 | 0.38 | ||
| Investments | n/a | n/a | n/a | ||
| Investment Properties | n/a | n/a | n/a | ||
| Other Financial Assets | n/a | n/a | n/a | ||
| Other Non-Current Assets | 0.05 | 0.05 | 0.05 | ||
| Total Non-Current Assets | 4.29 | 0.41 | 0.46 | ||
| Current Assets | |||||
| Inventories | 1.13 | n/a | n/a | ||
| Trade and Other Receivables | 3.54 | 2.20 | 0.17 | ||
| Cash at Bank and in Hand | 4.76 | 18.32 | 2.90 | ||
| Current Asset Investments | 8.04 | n/a | n/a | ||
| Other Current Assets | n/a | n/a | 0.76 | ||
| Total Current Assets | 17.48 | 20.51 | 3.82 | ||
| Other Assets | n/a | n/a | n/a | ||
| Total Assets | 21.77 | 20.92 | 4.28 | ||
| Current Liabilities | |||||
| Borrowings | 0.20 | 0.13 | 0.11 | ||
| Other Current Liabilities | 3.53 | 2.14 | 1.30 | ||
| Total Current Liabilities | 3.73 | 2.27 | 1.41 | ||
| Net Current Assets | n/a | n/a | n/a | ||
| Non-Current Liabilities | |||||
| Borrowings | 0.09 | 0.11 | 1.89 | ||
| Provisions | 0.50 | n/a | n/a | ||
| Other Non-Current Liabilities | n/a | n/a | 0.21 | ||
| Total Non-Current Liabilities | 0.58 | 0.11 | 2.10 | ||
| Net Assets | 17.45 | 18.55 | 0.77 | ||
| Capital and Reserves | |||||
| Share Capital | 0.31 | 0.28 | 0.03 | ||
| Share Premium Account | 28.98 | 23.35 | 11.59 | ||
| Other Reserves | 14.35 | 11.97 | 1.04 | ||
| Retained Earnings | -26.18 | -17.05 | -11.89 | ||
| Shareholders Funds | 17.45 | 18.55 | 0.77 | ||
| Minority Interests / Other Equity | n/a | n/a | n/a | ||
| Total Equity | 17.45 | 18.55 | 0.77 | ||
| 31-12-2022 | 31-12-2021 | 31-12-2020 | |||
| Operating Margin | -442.36% | -556.04% | -201.76% | ||
| Return on Capital Employed | -71.65% | -34.34% | -128.52% | ||
| Dividend Cover | n/a | n/a | n/a | ||
| Dividend Yield | n/a | n/a | n/a | ||
| PE Ratio | n/a | n/a | n/a | ||
| PEG | n/a | n/a | n/a | ||
| Dividend per Share Growth | n/a% | n/a% | n/a% | ||
| Net Asset Value per Share | 45.90p | 60.48p | 2.40p |